ArticleJournal of vascular surgery cases and innovative techniques2026
How I do it: Zone 0 arch treatment with laser in situ fenestrated endograft repair.
Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endovascular treatment of the aortic arch is an attractive option for the many patients who are at high risk for open surgical treatment. The complexity of the repair increases with more proximal treatment with a correlation between complications, such as strike, the closer to the aortic root. Given the paucity of commercially available branched devices, and the need for cervical debranching procedures, a total endovascular solution for the aortic arch is still lacking in the United States. Trial devised are being evaluated in highly selected anatomical cohorts; however, a critical need for a minimally invasive solution exists. Laser fenestration has been proposed as a mechanism to bridge the gap between trial and commercially available devices in poor risk surgical patients. In this article, we present techniques for laser in situ fenestrated endograft repair to the aortic arch.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.